Renal cell cancer: is immunotherapy dead? [Ann Oncol. 2007]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

1: Ann Oncol. 2007 Jul;18 Suppl 9:ix94-7. Links

Renal cell cancer: is immunotherapy dead?

South West Wales Cancer Institute & the University of Wales Swansea, School of Medicine, Singleton Hospital, Swansea, UK.

PMID: 17631604 [PubMed - indexed for MEDLINE]

ReviewImmunotherapeutic approaches for renal cancer.
Folia Biol (Praha). 2002; 48(5):167-81.

[Folia Biol (Praha). 2002]
Review[Immunotherapy of metastatic renal cell cancer]
Urologe A. 1993 Sep; 32(5):360-73.

[Urologe A. 1993]
ReviewBiologic response modifiers in the therapy of metastatic renal cell carcinoma.
Semin Oncol. 1988 Aug; 15(4):396-407.

[Semin Oncol. 1988]
ReviewImmunotherapy for renal cell cancer.
J Clin Oncol. 2006 Dec 10; 24(35):5576-83.

[J Clin Oncol. 2006]
ReviewImmunotherapy for renal cell cancer.
QJM. 1998 Sep; 91(9):597-602.

[QJM. 1998]
» See reviews... | » See all...

Glatiramer Acetate (Copaxone, Avonex, Rebif, ...)
How effective are disease-modifying drugs in the treatment of multiple sclerosis?
Source: AHFS Consumer Medication Information

Your browsing activity is empty.

Activity recording is turned off.

Display Show